Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 15,050
0.00 (0.00%)
At close: Feb 19, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 204 billion as of February 20, 2026. Its market cap has decreased by -10.06% in one year.
Market Cap
204.00B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
15,050.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 204.00B, an increase of 92.09%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 201.99B | 15.04% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 273.91B |
| Prestige Biologics | 221.98B |
| ISU Abxis | 219.90B |
| Vaxcell-Bio Therapeutics | 217.69B |
| QuadMedicine | 208.91B |
| Bio Solution | 205.95B |
| Kangstem Biotech | 196.10B |
| TiumBio | 175.63B |